OR WAIT null SECS
November 17, 2014
After being plagued by numerous delays, Lemtrada (alemtuzumab) has finally been approved by FDA for the treatment of multiple sclerosis.
November 15, 2014
Advanced analytical methods are speeding up the targeted evaluation of potential viral contaminants.
November 12, 2014
Threshold Pharmaceuticals' anticancer drug TH-302 receives FDA Fast Track designation.
November 07, 2014
ANSM wants company data on the benefits and risks of using Avastin over Lucentis in the treatment of wet age-related macular degeneration.
November 06, 2014
Catalent Pharma Solutions announces additional packaging and storage space for highly potent and cytotocix drugs at Kansas City facility.
November 04, 2014
AstraZeneca announced a partnership with Pharmacyclics and Janssen for combination trials of MEDI4736 (AstraZeneca) with Imbruvica (Pharmacyclics and Janssen) for the treatment of hematologic cancers.
November 03, 2014
Spectranetics announced that it acquired Covidien's drug-coated balloon platform, Stellarex, for $30 million.
November 02, 2014
Manufacturers face regulatory overhaul, while brand-generic debates escalate over biosimilars and labeling changes.
The author reviews the challenges in delivering macromolecule biologics.
Measuring syringe plunger force using a texture analyzer instrument.